Avalyn Pharma Funding: $211M Raised, Series B (2020)

Avalyn Pharma funding overview

Avalyn Pharma is a Biotech company based in Seattle. Avalyn Pharma has raised $211M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Avalyn Pharma runs through 2020; nothing later has been disclosed. Investors on record include SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital and 4 others. 10 distinct backers are named across the disclosed rounds.

Avalyn Pharma at a glance

Total raised: $211M
Latest round: Series B
Latest round date: January 2020
Industry: Biotech
Headquarters: Seattle
Notable investors: SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital, Novo Holdings, TPG Biotech

Frequently asked about Avalyn Pharma funding

How much has Avalyn Pharma raised?: Avalyn Pharma has raised $211M in total disclosed funding across the rounds on record.
Who has invested in Avalyn Pharma?: SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital are named among the investors backing Avalyn Pharma.
What was the latest Avalyn Pharma funding round?: The most recent disclosed round is a Series B, announced in January 2020.
Where is Avalyn Pharma based?: Avalyn Pharma is based in Seattle.
What sector does Avalyn Pharma operate in?: Avalyn Pharma is tracked under Biotech from Seattle, with $211M in disclosed funding.
When did Avalyn Pharma last raise?: The last disclosed Avalyn Pharma round closed in January 2020 at Series B.

Round data for Avalyn Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.

Avalyn Pharma Funding: $211M Raised, Series B (2020)

Avalyn Pharma funding overview

Avalyn Pharma at a glance

Frequently asked about Avalyn Pharma funding

Companies related to Avalyn Pharma (39)

Browse related funding lists (7)